Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2022

May 17, 2022

SELL
$37.46 - $42.44 $2.59 Million - $2.93 Million
-69,100 Reduced 73.75%
24,600 $958,000
Q4 2021

Feb 15, 2022

SELL
$35.17 - $42.48 $946,073 - $1.14 Million
-26,900 Reduced 22.31%
93,700 $3.73 Million
Q3 2021

Nov 16, 2021

BUY
$36.14 - $42.24 $4 Million - $4.68 Million
110,700 Added 1118.18%
120,600 $4.36 Million
Q2 2021

Aug 16, 2021

BUY
$39.85 - $46.63 $91,655 - $107,249
2,300 Added 30.26%
9,900 $406,000
Q1 2021

May 18, 2021

BUY
$42.34 - $52.82 $321,784 - $401,432
7,600 New
7,600 $332,000

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $11.2B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.